Anticardiolipin and Anti-β2-GPI are two distinct populations of autoantibodies

Thrombosis and Haemostasis

Volumn 75, Issue 2, 1996, Pages 303-308

  Sorice, M ^a   Circella, A ^a   Griggi, T ^a   Garofalo, T ^a   Nicodemo, G ^a   Pittoni, V ^a   Pontieri, G M ^a   Lenti, L ^a   Valesini, G ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY; CROSS REACTING ANTIBODY; IMMUNOGLOBULIN G; PHENYL ISOTHIOCYANATE; PHOSPHOLIPID; PHOSPHOLIPID ANTIBODY;

ADOLESCENT; ADULT; AGED; ANTIBODY PRODUCTION; ANTIGEN BINDING; ANTIGENICITY; ARTICLE; BINDING SITE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHOOL CHILD;

EID: 0029670445     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1650265     Document Type: Article

References (37)

1. Hughes GRV. The anticardiolipin syndrome. Clin Exp Rheumatol 1985; 3: 285-6.
2. Hughes GRV, Harris EN, Gharavi AE. The anticardiolipin syndrome. J Rheumatol 1986; 13: 486-9.
3. Harris EN, Gharavi AE, Loizou S Crossreaccivhy of antiphospholipid antibodies J Clin Lab Immunol 1985; 16: 1-6.
4. Gharavi AE, Harris EN, Asherson RA, Hughes GV. Anticardiolipin antibodies: Isotype, distribution and phospholipid specificity. Ann Rheum Dis 1987; 46: 1-6.
5. Galli M, Comfurius P, Maassen C, Hemker HC, De Baets MH, van Breda-Vriesman PJC, Barbui T, Zwaal RFA, Bevers EM. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 1990; 355: 1544-7.
6. Mc Neil HP, Simpson RJ, Chesterman CN, Krilis SA. Antiphospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation; beta-2 glycoprotein-I (apolipoprotein II). Proc Natl Acad Sci USA 1990; 87: 4120-4.
7. Matsuura E, Igarashi Y, Fujimoto M, Ichikawa K, Koike T. Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet 1990; 336: 177-8.
8. 2-glycoprotein I complex is an antigen for anticardiolipin antibodies occurring in autoimmune disease but not with infection. Lupus 1992; 1: 75-81.
9. Hunt J, Krilis S. The fifth domain of b2-glycoprotein I contains a phospholipid binding site (Cys 281-Cys 288) and a region recognized by anticardiolipin antibodies. J Immunol 1994; 152: 653-9.
10. Rauch J, Janoff AS. The nature of anti-phospholipid antibodies. J Rheumatol 1992; 19: 1782-5.
11. 2 glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus. Am J Med 1992; 93: 181-6.
12. 2-glycoprotein I. J Clin Invest 1992; 90: 1100-4.
13. 2 glycoprotein I is potentiated by a distinct subgroup of anticardiolipin antibodies. Thromb Haemost 1992; 68: 297-300.
14. 2 glycoprotein I. J ClinPathol 1993; 46: 665-7.
15. Sorice M, Griggi T, Circella A, Garofalo T, d'Agostino F, Pittoni V, Pontieri GM, Lenti L, Valesini G. Detection of antiphospholipid antibodies by immunostaining on thin layer chromatography plates. J Immunol Methods 1994; 173: 49-54.
16. Tan EN, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Shaller JG, Talal N, Winchester RG. The 1982 revised criteria for the classification of Systemic Lupus Erythematosus. Arthr Rheum 1982; 25: 1271-7.
17. Harris EN. The Second International Anti-Cardiolipin Standardization Workshop/The Kaps Group. Am J Clin Pathol 1990; 94: 476-84.
18. 2 glycoprotein I antibodies: a marker of antiphospholipid syndrome? Lupus 1995; 4: 122-30.
19. th edn. Weir DM (ed). Oxford: Blackwell Scientific 1986; 13: 1.
20. Laemmli UK. Cleavage of structural proteins during the assembly of the head of the bacteriophage T4. Nature 1970; 227: 680-5.
21. Towbin H, Staehelin T, Gordon J. Elecrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979; 76: 4350-4.
22. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with Folin phonol reagent. J Biol Chem 1951; 193: 265-75.
23. Sammons DW, Adams LD, Nishizawa EE. Ultrasensitive silver-based color staining of polypeptides in polyacrylamide gels. Electrophoresis 1981; 2: 135-41.
24. Stark GR. Recent developments in chemical modification and sequential degradation of protein. Adv Prot Chem 1970; 24: 261-308.
25. Polz E, Kostaer GM. The binding of beta2-gylcoprotein I to human serum lipoproteins distribution among density fraction. FEBS Lett 1979; 102: 183-6.
26. Arvieux J, Roussel B, Jacob MC, Colomb MG. Measurement of anti-phospholipid antibodies by ELISA using beta 2-glycoprotein 1 as an antigen. J Immunol Methods 1991; 193: 223-9.
27. Matsuura E, Igarashi Y, Fujimoto M, Ichikawa K, Suzuki T, Sumida T, Yasuda T, Koike T. Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor. J Immunol 1992; 148: 3885-91.
28. Gharavi AE. Antiphospholipid cofactor. Stroke 1992; 23 (Suppl I): 1-10.
29. Sammaritano LR, Lockshin MD, Gharavi AE. Antiphospholipid antibodies differ in aPL cofactor requirement. Lupus 1992; 1: 51-6.
30. 2-GPI cofactor. Autoimmunity 1992; 14: 105-10.
31. 2-glycoprotein I in the absence of phospholipid. Br J Haematol 1992; 82: 571-4.
32. 2GPI) enhanced cardiolipin binding activity but is not the antigen for antiphospholipid antibodies. Br J Haematol 1992, 82: 565-70.
33. 2-glycoprotein I antibodies. Clin Rev Allergy Immunol 1995; 13: 11-17.
34. 2-glycoprotein I is bound to a suitable surface. Thromb Haemost 1995; 73: 29-34.
35. 2-glycoprotein I in the absence of phospholipid. Importance of Ag density and bivalent binding. J Immunol 1995; 154: 954-60.
36. 2-glycoprotein I antibodies in autoimmune patients. Clin Exp Immunol 1994; 95: 310-5.
37. Roubey RAS. Autoantibodies to phospholipid-binding plasma proteins: a new view of Lupus Anticoagulants and other "Antiphospholipid" autoantibodies. Blood 1994; 84: 2854-67.